Valley National Bancorp Common Stock vs 22nd Century Group Inc — how do they compare? Valley National Bancorp Common Stock trades at $12.62 (market cap $7.05B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Valley National Bancorp Common Stock is far larger — about 11340.4× 22nd Century Group Inc's market cap, and Valley National Bancorp Common Stock pays a 3.45% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Valley National Bancorp Common Stock for 1 Days and 22nd Century Group Inc for 32 Days on average.
| VLY | XXII | |
|---|---|---|
Market Cap | $7.05B | $621.67K |
Volume | 7,669,925 | 45,625 |
Sector | Financials | Consumer Staples |
52-Week High | $15.19 | $483.00 |
52-Week Low | $9.72 | $0.80 |
Typical Hold Time | 1 Days | 32 Days |
Enterprise Value | $9.55B | -$3.69M |
Dividend Yield | 3.45% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Valley National Bancorp is a financial holding company whose main subsidiary is Valley National Bank. It provides commercial, retail, trust, and investment services across several U.S. states.
Read more on VLY →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →